Clin2
NCT07057674Likely a fitRecruiting

Study of HS-20094 in overweight or obese adults

Overweight or Obesity

Part of Hormones & metabolism clinical trials.

This study tests a new medication called HS-20094 for people who are overweight or have obesity. It is designed to help with weight loss and will last for several months to see how safe and effective the medicine is.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
144 people
Ages
18 years to 65 years
Study type
Interventional

Who can take part

  • Be between 18 and 65 years old
  • Have a BMI of 24 or more (a measure of weight relative to height)
  • Have had a stable weight for at least 12 weeks (not gaining or losing more than 5% of your body weight)
  • Not have diabetes or conditions related to the pancreas or thyroid
  • Not be taking certain medications that affect weight or blood sugar
  • Agree to use effective birth control if you are able to become pregnant or father a child

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07150962Recruiting· Phase 1
Testing a new version of an obesity treatment pill

This trial compares two versions of the study drug HRS9531 in people with overweight or obesity to see which one works better in the body. It may help find a more effective treatment for weight management.

Hefei, Anhui
NCT06830343Recruiting· Phase 1
Safety study of SYH9017 for overweight and obesity

This study tests a new medication called SYH9017 for people who are overweight or have obesity. It aims to see how safe the drug is, how well it is tolerated, and how the body processes it. Participants will receive either the drug or a placebo and be monitored closely.

Beijing, Beijing Municipality
NCT07690826Not yet recruiting· Phase 2
Study of HRS-4729 injection for weight loss in obesity

This trial tests an investigational injection called HRS-4729 for weight loss in people with obesity. It checks if the drug is safe and effective when used along with diet and exercise.

Shanghai, Shanghai Municipality
NCT07776041Not yet recruiting· Phase 1
Study of a new injection for healthy volunteers

This trial tests a new injection called SYH2092 in healthy adults, not for treating a disease. Participation helps researchers understand how the drug works in the body and if it is safe. If you qualify, you may be compensated for your time.

Melbourne, Victoria
NCT07274137Not yet recruiting· Phase 3
Weight-loss drug study for people with obesity or overweight

This trial tests an investigational weight-loss medication (MDR-001) for people who are overweight or have obesity. Researchers want to see if this drug helps with weight loss and is safe when taken along with diet and exercise.

Beijing
NCT07040046Recruiting· Phase 1
Study of HS-10542 in healthy volunteers

This trial tests an investigational drug, HS-10542, in healthy adults to see how it is processed by the body and to check for side effects. You must be willing to receive two vaccines before the study starts.

Qingdao, Shandong

Hear when a new Overweight or Obesity trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.